nach oben

Current Diabetes Reports

Erschienen in:

01.11.2019 | Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

Timing of Insulin with Meals in the Hospital: a Systems Improvement Approach

verfasst von: Kathleen Dungan

Erschienen in: Current Diabetes Reports | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Coordination of glucose monitoring, mealtimes, and insulin delivery in the hospital is complex, involving interactions between multiple key agents and overlapping workflows. The purpose of this review is to evaluate the scope of the problem as well as to assess evidence for interventions.

Recent Findings

In recent years, there has been an emphasis on systems-based approaches which address multiple contributing components of the problem at once in an effort to more seamlessly integrate workflows. Technological advances, such as decision support systems and advances in automated insulin delivery, and strategies that minimize the need for complex insulin regimens hold promise for future study.

Summary

Evaluation of the coordination of insulin delivery is limited by a lack of standardized metrics and systematically collected mealtimes. Nevertheless, successful efforts include system-wide multicomponent interventions, though advances in therapeutic approaches may be of value.

Swanson CM, Potter DJ, Kongable GL, Cook CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011;17:853–61. https://doi.org/10.4158/EP11042.OR.CrossRefPubMed

Fraze TK, Jiang HJ, Burgess J. Hospital stays for patients with diabetes, 2008. HCUP statistical brief #93. Rockville: Agency for Healthcare Research and Quality; 2010. http://www.ncbi.hlm.nih.gov/books/NBK52658/

van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. https://doi.org/10.1056/NEJMoa011300.CrossRef

Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61. https://doi.org/10.2337/dc10-1407.CrossRefPubMedPubMedCentral

Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82. https://doi.org/10.1210/jcem.87.3.8341.CrossRefPubMed

Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38. https://doi.org/10.1210/jc.2011-2098.CrossRefPubMed

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119–31. https://doi.org/10.2337/dc09-9029.CrossRefPubMedPubMedCentral

American Diabetes Association. Standards of medical care in diabetes 2019. Diabetes Care. 2019;42:S173–81. https://doi.org/10.2337/dc19-S015.CrossRef

Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes. Diabetes Care. 2007;30:367–9. https://doi.org/10.2337/dc06-1715.CrossRefPubMed

10.

Carey M, Boucai L, Zonszein J. Impact of hypoglycemia in hospitalized patients. Curr Diab Rep. 2013;13:107–13. https://doi.org/10.1007/s11892-012-0336-x.CrossRefPubMed

11.

https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdf. Accessed 5/26/19.

12.

http://www.ihi.org/explore/highalertmedicationsafety/pages/default.aspx. Accessed 5/26/2019.

13.

Classen DC, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36:12–21.CrossRef

14.

• Institute for Safe Medication Practices (ISMP). ISMP guidelines for optimizing safe subcutaneous insulin use in adults; 2017. https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP138-Insulin%20Guideline-051517-2-WEB.pdf. Site accessed 5/26/2019. This publication identifies and defines insulin errors (including inadequate management strategies) and provides high-level systems-based strategies to address.

15.

Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70:1404–13. https://doi.org/10.2146/ajhp130169.CrossRefPubMed

16.

http://www.jointcommission.org/assets/1/6/DSC_teleconference__IPD_111213.pdf. Accessed 5/26/2019.

17.

http://www.ihi.org/resources/Pages/Changes/ReduceAdverseDrugEventsInvolvingInsulin.aspx. Accessed 5/26/2019.

18.

Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size. Clin Ther. 2004;26:1492–7. https://doi.org/10.1016/j.clinthera.2004.09.001.CrossRefPubMed

19.

Ratner R, Wynne A, Nakhle S, Brusco O, Vlajnic A, Rendell M. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096). Diabetes Obes Metab. 2011;13:1142–8. https://doi.org/10.1111/j.1463-1326.2011.01478.x.CrossRefPubMedPubMedCentral

20.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA. Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients. Diabetes Care. 1998;21:570–3. https://doi.org/10.2337/diacare.21.4.570.CrossRefPubMed

21.

Freeland B, Penprase BB, Anthony M. Nursing practice patterns: timing of insulin administration and glucose monitoring in the hospital. Diabetes Educ. 2011;37:357–62. https://doi.org/10.1177/0145721711401669.CrossRefPubMed

22.

Lampe J, Penoyer DA, Hadesty S, Bean A, Chamberlain L. Timing is everything: results to an observational study of mealtime insulin practices. Clin Nurse Spec. 2014;28:161–7. https://doi.org/10.1097/NUR.0000000000000045.CrossRefPubMed

23.

• Alwan D, Chipps E, Yen P, Dungan D. Evaluation of the timing and coordination of prandial insulin administration in the hospital. Diabetes Res and Clin Pract. 2017;131:18–32. https://doi.org/10.1016/j.diabres.2017.06.021 This is the largest study (retrospective observational design) to date to characterize the timing of insulin relative to glucose monitoring and impact on glucose control. The study also assessed nursing perceptions. CrossRef

24.

https://psnet.ahrq.gov/primers/primer/42/patient-safety-101. Accessed 5/26/2019.

25.

• Bain A, Hasan SS, Babar ZU. Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review. Diabetes Med. 2019. https://doi.org/10.1111/dme.13982 This was a systematic review that assessed interventions which address insulin prescribing errors. CrossRef

26.

McKibbon KA, Lokker C, Handler SM, Dolovich LR, Holbrook AM, O'Reilly D, et al. The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc. 2012;19:22–30. https://doi.org/10.1136/amiajnl-2011-000304.CrossRefPubMed

27.

Kamarudin G, Penm J, Chaar B, Moles R. Educational interventions to improve prescribing competency: a systematic review. BMJ Open. 2013;3:e003291. https://doi.org/10.1136/bmjopen-2013-003291.CrossRefPubMedPubMedCentral

28.

Houck PM, Tirumalasetty NN, Meadows RY. Insulin administration and meal delivery coordination for hospitalized patients. Ochsner J. 2013;13:327–33.PubMedPubMedCentral

29.

Wright K. Student nurses need more than math to improve their drug calculating skills. Nurse Educ Today. 2007;27:278–85. https://doi.org/10.1016/j.nedt.2006.05.007.CrossRefPubMed

30.

• Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec. 2016;30:117–24. https://doi.org/10.1097/NUR.0000000000000190 This retrospective study described a single institution’s approach to improve the timing of insulin delivery in the hospital via a nurse centric intervention. CrossRefPubMed

31.

Pham JT, Schreiber P. Improving hyperglycemia management in the inpatient orthopaedic population with a special focus on mealtime insulin administration. University of California San Francisco School of Nursing. http://dne2.ucsf.edu/public/cripc/ebpabstract/pham-abst.pdf. Accessed 5/26/2019.

32.

Donihi AC, Abriola C, Hall R, Korytkowski MT. Getting the timing right in the hospital: synching insulin administration with meal tray arrival. American Diabetes Association 70th Scientific Sessions 2010. Abstract #1028P https://professional.diabetes.org/abstract/getting-timing-right-hospital-synching-insulin-administration-meal-tray-arrival. Accessed 5/26/2019.

33.

Yamamoto J, Abraham D, Malatestinic B. Improving insulin distribution and administration safety using Lean Six Sigma Methodologies. Hosp Pharm. 2010;45:212–24.CrossRef

34.

Yamamoto J, Abraham D, Malatestinic B. Facilitating process changes in meal delivery and radiological testing to improve inpatient insulin timing using Six Sigma method. Q Manage Health Care. 2010;19:189–200. https://doi.org/10.1097/QMH.0b013e3181eb137f.CrossRef

35.

Nirantharakumar K, Chen YF, Marshall T, Webber J, Coleman JJ. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabet Med. 2012;29:698–708. https://doi.org/10.1111/j.1464-5491.2011.03540.x.CrossRefPubMed

36.

• Donsa K, Beck P, Höll B, Mader JK, Schaupp L, Plank J, et al. Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a before and after study. Int J Med Inform. 2016;90:58–67. https://doi.org/10.1016/j.ijmedinf.2016.03.007 This was a post hoc analysis of a randomized study of a computerized insulin management system. The timing of glucose monitoring and insulin delivery did not impact glucose control though the interval was < 1 hour on average. CrossRefPubMed

37.

Campion TR Jr, Waitman LR, Lorenzi NM, May AK, Gadd CS. Barriers and facilitators to the use of computer-based intensive insulin therapy. Int J Med Inform. 2011;80:863–71. https://doi.org/10.1016/j.ijmedinf.2011.10.003.CrossRefPubMedPubMedCentral

38.

Campion TR Jr, Waitman LR, May AK, Ozdas A, Lorenzi NM, Gadd CS. Social, organizational, and contextual characteristics of clinical decision support systems for intensive insulin therapy: a literature review and case study. Int J Med Inform. 2010;79:31–43. https://doi.org/10.1016/j.ijmedinf.2009.09.004.CrossRefPubMed

39.

• Thabit H, Hovorka R. Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings. Diabetes Med. 2018;35:460–71. https://doi.org/10.1111/dme.13563 This review characterizes the role of novel treatments and technologies under study in the hospital, including novel automated insulin dosing strategies. CrossRef

40.

Neubauer KM, Mader JK, Höll B, Aberer F, Donsa K, Augustin T, et al. Standardized glycemic management with a computerized workflow and decision support system for hospitalized patients with type 2 diabetes on different wards. Diabetes Technol Ther. 2015;17:685–92. https://doi.org/10.1089/dia.2015.0027.CrossRefPubMedPubMedCentral

41.

• Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41:1579–89. https://doi.org/10.2337/dci18-0002 This is a recent review article which describes the appropriate use of continuous glucose monitoring systems in the hospital. CrossRefPubMedPubMedCentral

42.

• Wallia A, Umpierrez GE, Rushakoff RJ, Klonoff DC, Rubin DJ, Hill Golden S, et al. Consensus statement on inpatient use of continuous glucose monitoring. J Diabetes Sci Technol. 2017;11:1036–44. https://doi.org/10.1177/1932296817706151 This is an expert consensus statement describes the appropriate use of continuous glucose monitoring systems in the hospital and future areas for research. CrossRefPubMedPubMedCentral

43.

Thabit H, Hovorka R. Glucose control in non-critically ill in patients with diabetes: towards closed-loop. Diabetes Obes Metab. 2014;16:500–9. https://doi.org/10.1111/dom.12228.CrossRefPubMed

44.

• Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label,non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5:125–33. https://doi.org/10.1016/S2213-8587(16)30402-8 This was a randomized multi-center study that demonstrated similar safety and efficacy of Sitagliptin + basal + correction insulin as an alternative strategy to basal + prandial + correction insulin. CrossRefPubMed

45.

Pasquel FJ, Gomez-Huelgas R, Anzola I, Oyedokun F, Haw JS, Vellanki P, et al. Predictive value of admission hemoglobin A1c on inpatient glycemic control and response to insulin therapy in medicine and surgery patients with type 2 diabetes. Diabetes Care. 2015;38:e202–3. https://doi.org/10.2337/dc15-1835.CrossRefPubMedPubMedCentral

46.

• Heise T, Pieber TR, Danne T, Erichsen L, Haahr H. A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in adults with type 1 diabetes. Clin Pharmacokinet. 2017;56:551–9. https://doi.org/10.1007/s40262-017-0514-8 This was a pooled analysis of studies indicating the potential utility of faster acting insulins for post-meal insulin administration, which is relevant for the hospitalized patient who is getting post-meal insulin. CrossRefPubMedPubMedCentral

47.

• Russell-Jones D, Bode BW, De Block C, Franek E, Heller SR, Mathieu C, et al. Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1). Diabetes Care. 2017;40:943–50. https://doi.org/10.2337/dc16-1771 This was a randomized controlled trial using CGM to demonstrate the potential utility of faster acting insulins for post-meal insulin administration, which is relevant for the hospitalized patient who is getting post-meal insulin. CrossRefPubMed

Titel: Timing of Insulin with Meals in the Hospital: a Systems Improvement Approach
verfasst von: Kathleen Dungan
Publikationsdatum: 01.11.2019
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 11/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-019-1232-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control

Correction to: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition

Replacing Pumps with Light Controlled Insulin Delivery

Pregnancy and Gestational Diabetes Mellitus (GDM) in North American Indian Adolescents and Young Adults (AYA): Implications for Girls and Stopping GDM

Benefit-to-Risk Balance of Weight Loss Interventions in Older Adults with Obesity

Diabetes and Disasters: Recent Studies and Resources for Preparedness